Eva CoreyBS, MS, PhD
Dr. Eva Corey’s major research objective is to investigate the molecular events associated with the progression of prostate cancer and prostate cancer metastasis to bone. As part of this research, Dr. Corey has also been involved in the establishment and characterization of novel prostate cancer models and has used these models to investigate the biology of prostate cancer as well as evaluate the efficacy of novel pipeline agents as potential treatment for this disease. She is co-Director of the GU Cancer Research Lab.
Dr. Corey received her RNDr. (M.S.) in 1989 from Charles University, Prague, Czechoslovakia, and her Ph.D. in Organic Chemistry with specialization in Peptide Chemistry from the Czechoslovak Academy of Sciences, Prague, Czechoslovakia. She did postdoctoral studies in London at the University of London, School of Pharmacy, on synthesis of fragments of HIV p24; at the University of Colorado with Professor John M. Stewart in Denver, CO, on synthesis, purification, and characterization of an artificial enzyme; and at the University of Washington, Seattle, WA, where she concentrated on various aspects of prostate cancer.